Verizon Communications Inc. (NYSE:VZ) shares moved down -1.10% in last trading session and ended the day at $44.82. VZ Gross Margin is 60.00% and its has a return on assets of 4.30%. Verizon Communications Inc. (NYSE:VZ) quarterly performance is -0.54%.
Verizon Communications Inc. (NYSE:VZ) said that, it will start field trials for its upcoming 5G wireless network with its partners in 2016. The company is preparing for initial deployment of the next-generation 5G wireless networks in the U.S. in 2017. Verizon’s CEO Lowell McAdam recently confirmed the news at a Business Insider event in New York.
Citizens Holding Company (NASDAQ:CIZN) ended the last trading day at $20.81. Company weekly volatility is calculated as 1.04% and price to cash ratio as 4.74. Citizens Holding Company (NASDAQ:CIZN) showed a weekly performance of -2.89%.
Citizens Holding Company (NASDAQ:CIZN) announced that its Board of Directors declared a cash dividend of $0.24 per share payable December 31, 2015, to shareholders of record as of December 15, 2015.
On 11 December, JD.com, Inc. (NASDAQ:JD) shares moved down -3.32% and was closed at $30.55. JD.com, Inc. (NASDAQ:JD) year to date (YTD) performance is 32.02%.
JD.com, Inc. (NASDAQ:JD) said that, it is rolling out a service with a leading Chinese supermarket chain that will allow shoppers to order groceries and fresh food and have them delivered to their homes within two hours.
Juno Therapeutics Inc. (NASDAQ:JUNO) shares moved down -5.04% in last trading session and ended the day at $44.26. JUNO has a return on assets of -46.50%. Juno Therapeutics Inc. (NASDAQ:JUNO) quarterly performance is 8.32%.
On 7 December, Juno Therapeutics Inc. (NASDAQ:JUNO) announced, in partnership with its collaborators, that clinical data from separate trials for chimeric antigen receptor (CAR) T cell product candidates, JCAR015 and JCAR014, demonstrated encouraging clinical responses in patients relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL). JCAR015 and JCAR014 results presented in oral and poster presentations, respectively, at the 57th Annual Meeting of the American Society of Hematology (ASH) in Orlando.
Vertex Energy, Inc. (NASDAQ:VTNR) caters to the Industrial Goods space. It has a net profit margin of -16.90% and weekly performance is -23.20%. On the last day of trading company shares ended up at $1.39. Vertex Energy, Inc. (NASDAQ:VTNR) distance from 50-day simple moving average (SMA50) is -6.67%.
Zacks downgraded shares of Vertex Energy, Inc. (NASDAQ:VTNR) from a hold rating to a sell rating in a research report published on Thursday, Analyst Ratings Network.com reports.
Leave a Reply